DrugApproved
Enlicitide (LIPFENDRA)
enlicitide
FDA 17.07.2026: первый пероральный PCSK9-ингибитор для снижения LDL-C у взрослых с гиперхолестеринемией, включая HeFH.
No news refers to this card yet.
Scales
Identifiers
- INN
- enlicitide
Details
- Status
- Approved
- Class
- oral PCSK9 inhibitor
- Trade names
- LIPFENDRA
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.